Yuanyuan Zhang
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 9
- Metal complexes synthesis and properties 8
- Cancer-related Molecular Pathways 6
- Pharmacology top 5%
- Berberine and alkaloids research 5
- Pharmacology top 10%
- Berberine and alkaloids research 5
-
- Cancer therapeutics and mechanisms 5
-
- Traditional Chinese Medicine Analysis 7
-
- Microtubule and mitosis dynamics 5
-
- Pediatric Hepatobiliary Diseases and Treatments 5
- Cited by
- OncologyPharmacology
- Journals
- Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Yuanyuan Zhang
87 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 130
- Oncology 399
- Pharmacology 111
- Pharmacology 131
- Cancer Research 109
- Molecular Biology 467
Countries citing papers authored by Yuanyuan Zhang
This map shows the geographic impact of Yuanyuan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Zhang more than expected).
Fields of papers citing papers by Yuanyuan Zhang
This network shows the impact of papers produced by Yuanyuan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Zhang. The network helps show where Yuanyuan Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanyuan Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 19 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 14 | |
| 14 | 2022 | 14 | |
| 15 | 2021 | 20 | |
| 16 | 2020 | 3 | |
| 17 | 2018 | 24 | |
| 18 | 2016 | 23 | |
| 19 | 2013 | 42 | |
| 20 | 2011 | 7 |
About Yuanyuan Zhang
Yuanyuan Zhang is a scholar working on Aging, Oncology and Complementary and alternative medicine, having authored 90 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Metal complexes synthesis and properties (8 papers), Traditional Chinese Medicine Analysis (7 papers), Cancer-related Molecular Pathways (6 papers), Microtubule and mitosis dynamics (5 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers), Berberine and alkaloids research (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (399 citations), Pharmacology (111 citations) and Pharmacology (131 citations). Yuanyuan Zhang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yunjun Liu, Huiwen Zhang, Tian Li, Mary Vore, Yi Zhou, Xi Chu, Jeffrey E. Edwards, Kenneth R. Brouwer, Li Chu and Jonathan P. Jackson. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.